Dolby Laboratories (NYSE:DLB) Issues FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.190-4.340 for the period, compared to the consensus earnings per share estimate of 3.770. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q1 2026 guidance to 0.790-0.940 EPS.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DLB. Tigress Financial upped their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research note on Friday, August 15th. Barrington Research reiterated an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Robert W. Baird assumed coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $95.75.

Dolby Laboratories Stock Up 0.9%

Shares of Dolby Laboratories stock traded up $0.58 during trading hours on Tuesday, hitting $65.13. 904,009 shares of the company’s stock traded hands, compared to its average volume of 455,687. Dolby Laboratories has a twelve month low of $64.02 and a twelve month high of $89.66. The company has a market cap of $6.24 billion, a PE ratio of 23.86 and a beta of 0.97. The stock has a 50 day simple moving average of $69.07 and a 200-day simple moving average of $72.58.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This represents a 9.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the firm’s stock in a transaction on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the transaction, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at approximately $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 57,000 shares of company stock worth $4,037,690 over the last ninety days. 38.39% of the stock is currently owned by corporate insiders.

Institutional Trading of Dolby Laboratories

Several institutional investors and hedge funds have recently bought and sold shares of the company. Aquatic Capital Management LLC bought a new stake in Dolby Laboratories during the third quarter valued at $56,000. iSAM Funds UK Ltd acquired a new stake in shares of Dolby Laboratories in the 3rd quarter worth approximately $68,000. US Bancorp DE boosted its stake in Dolby Laboratories by 31.3% during the 3rd quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after purchasing an additional 341 shares in the last quarter. Osaic Holdings Inc. boosted its stake in Dolby Laboratories by 165.8% during the second quarter. Osaic Holdings Inc. now owns 2,541 shares of the electronics maker’s stock valued at $195,000 after buying an additional 1,585 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Dolby Laboratories by 273.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after purchasing an additional 1,902 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.